HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

motexafin lutetium (Lutrin)

structure given in first source
Also Known As:
Lutrin; lutetium texaphyrin; Lu-Tex; Optrin; PCI 0123; PCI-0123; lutex
Networked: 33 relevant articles (0 outcomes, 9 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Busch, Theresa M: 6 articles (09/2010 - 03/2002)
2. Zhu, Timothy C: 6 articles (08/2008 - 01/2002)
3. Hahn, Stephen M: 5 articles (08/2008 - 01/2002)
4. Woodburn, K W: 4 articles (06/2001 - 03/2000)
5. Wang, Hsing-Wen: 3 articles (09/2010 - 03/2002)
6. Yodh, A G: 3 articles (10/2006 - 03/2002)
7. Hayase, M: 3 articles (06/2001 - 11/2000)
8. Yu, Guoqiang: 2 articles (09/2010 - 09/2006)
9. Finlay, Jarod: 2 articles (08/2008 - 01/2006)
10. Malkowicz, S Bruce: 2 articles (08/2008 - 09/2006)

Related Diseases

1. Prostatic Neoplasms (Prostate Cancer)
2. Atherosclerosis
3. Breast Neoplasms (Breast Cancer)
4. Macular Degeneration (Age-Related Maculopathy)
5. Coronary Artery Disease (Coronary Atherosclerosis)

Related Drugs and Biologics

1. motexafin lutetium (Lutrin)
2. Photosensitizing Agents (Photosensitizers)
3. 1-phenyl-3,3-dimethyltriazene (PDT)
4. Chlorides
5. padeliporfin
6. protoporphyrin IX
7. Singlet Oxygen
8. Prostate-Specific Antigen (Semenogelase)
9. Dihematoporphyrin Ether (Porfimer Sodium)
10. Solutions

Related Therapies and Procedures

1. Photochemotherapy (Photodynamic Therapy)
2. Phototherapy (Light Therapy)
3. Percutaneous Coronary Intervention
4. Stents
5. Drug Therapy (Chemotherapy)